Search
for
Sort by
Research 181–210 of 1000+
- Alopecia and hirsutism*
- S127 Regulation of hair growth
- ??-Hydroxy Acid???Based Cosmetic Procedures
- Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction
- The antiandrogens. When and how they should be used.
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice
- Treat androgenetic alopecia with antiandrogens, as well as other pharmacological and non-pharmacological interventions
- Antiandrogen Therapy for Female-Pattern Hair Loss
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Anti-Androgens
- Latent hazard in PC and BPH patients referred to antiandrogens:PC aggressiveness and NE differentiation
- [Antiandrogen therapy of acne, falling hair and hirsutism (author's transl)].
- Un nuevo anovulador antiandrogénico
- The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study
- Living Probiotic Microneedles Coordinate Antiandrogen and Nitric Oxide Therapy for Androgenetic Alopecia
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Spironolactone is an Effective and Well Tolerated Systemic Antiandrogen Therapy for Hirsute Women*
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women<sup>1</sup>
- Antiandrogen therapy for androgenetic alopecia
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- The Development and Evaluation of An Ovulation Inhibitor (Diane®) Containing An Antiandrogen
- Development and Validation of Androgen-induced Hair Loss and Anagen Induction Mouse Models for Pharmacological Evaluation of Anti-Androgenic Agents
- Anti-Hair Loss Potential of Perilla Seed Extracts: In Vitro Molecular Insights from Supercritical Fluid Extraction
- Cyanidin-3-O-glucoside and its derivative vitisin A alleviate androgenetic alopecia by exerting anti-androgen effect and inhibiting dermal papilla cell apoptosis